Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971031736> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W1971031736 endingPage "937" @default.
- W1971031736 startingPage "931" @default.
- W1971031736 abstract "Rivaroxaban (BAY 59-7939) is an oral, direct factor Xa inhibitor in clinical development for the prevention and treatment of venous thromboembolism (VTE). This analysis of pooled results from two phase II studies of rivaroxaban for VTE prevention after major orthopaedic surgery aimed to strengthen the conclusions of the individual studies. One study was conducted in patients undergoing total hip replacement (THR; N = 722), and one in patients undergoing total knee replacement (TKR; N = 621). In both studies, patients were randomized, doubleblind, to oral, twice-daily (bid) rivaroxaban beginning after surgery, or subcutaneous enoxaparin (40 mg once daily beginning before THR, and 30 mg bid beginning after TKR). Treatment continued until mandatory bilateral venography was performed 5-9 days after surgery. Total VTE (deep vein thrombosis, pulmonary embolism, and all-cause mortality) occurred in 16.1-24.4% of per-protocol patients receiving rivaroxaban 5-60 mg, and 27.8% receiving enoxaparin (n = 914). There was a flat dose response relationship between rivaroxaban and total VTE (p = 0.39). Major bleeding (safety population, n = 1,317) increased dose-dependently with rivaroxaban (p < 0.001), occurring in 0.9%, 1.3%, 2.1%, 3.9%, and 7.0% of patients receiving rivaroxaban total daily doses of 5, 10, 20, 40, and 60 mg, respectively, versus 1.7% of patients receiving enoxaparin. No routine coagulation monitoring was performed, and there were no significant differences between dose response relationships with rivaroxaban after THR and TKR. Overall, rivaroxaban total daily doses of 5-20 mg had the most favorable balance of efficacy and safety, relative to enoxaparin, for the prevention of VTE after major orthopaedic surgery." @default.
- W1971031736 created "2016-06-24" @default.
- W1971031736 creator A5002053398 @default.
- W1971031736 creator A5009167101 @default.
- W1971031736 creator A5012512308 @default.
- W1971031736 creator A5026613773 @default.
- W1971031736 creator A5039463274 @default.
- W1971031736 creator A5060633896 @default.
- W1971031736 creator A5061240133 @default.
- W1971031736 creator A5071835932 @default.
- W1971031736 creator A5083315102 @default.
- W1971031736 creator A5083647812 @default.
- W1971031736 creator A5086575517 @default.
- W1971031736 creator A5087035462 @default.
- W1971031736 creator A5088333216 @default.
- W1971031736 creator A5088406700 @default.
- W1971031736 date "2007-01-01" @default.
- W1971031736 modified "2023-09-26" @default.
- W1971031736 title "Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies" @default.
- W1971031736 doi "https://doi.org/10.1160/th07-01-0055" @default.
- W1971031736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17549294" @default.
- W1971031736 hasPublicationYear "2007" @default.
- W1971031736 type Work @default.
- W1971031736 sameAs 1971031736 @default.
- W1971031736 citedByCount "50" @default.
- W1971031736 countsByYear W19710317362012 @default.
- W1971031736 countsByYear W19710317362013 @default.
- W1971031736 countsByYear W19710317362014 @default.
- W1971031736 countsByYear W19710317362015 @default.
- W1971031736 countsByYear W19710317362019 @default.
- W1971031736 countsByYear W19710317362020 @default.
- W1971031736 countsByYear W19710317362021 @default.
- W1971031736 countsByYear W19710317362022 @default.
- W1971031736 crossrefType "journal-article" @default.
- W1971031736 hasAuthorship W1971031736A5002053398 @default.
- W1971031736 hasAuthorship W1971031736A5009167101 @default.
- W1971031736 hasAuthorship W1971031736A5012512308 @default.
- W1971031736 hasAuthorship W1971031736A5026613773 @default.
- W1971031736 hasAuthorship W1971031736A5039463274 @default.
- W1971031736 hasAuthorship W1971031736A5060633896 @default.
- W1971031736 hasAuthorship W1971031736A5061240133 @default.
- W1971031736 hasAuthorship W1971031736A5071835932 @default.
- W1971031736 hasAuthorship W1971031736A5083315102 @default.
- W1971031736 hasAuthorship W1971031736A5083647812 @default.
- W1971031736 hasAuthorship W1971031736A5086575517 @default.
- W1971031736 hasAuthorship W1971031736A5087035462 @default.
- W1971031736 hasAuthorship W1971031736A5088333216 @default.
- W1971031736 hasAuthorship W1971031736A5088406700 @default.
- W1971031736 hasConcept C126322002 @default.
- W1971031736 hasConcept C141071460 @default.
- W1971031736 hasConcept C2776265017 @default.
- W1971031736 hasConcept C2776301958 @default.
- W1971031736 hasConcept C2778104916 @default.
- W1971031736 hasConcept C2778269268 @default.
- W1971031736 hasConcept C2778336525 @default.
- W1971031736 hasConcept C2778661090 @default.
- W1971031736 hasConcept C2778959117 @default.
- W1971031736 hasConcept C2779161974 @default.
- W1971031736 hasConcept C2780868729 @default.
- W1971031736 hasConcept C2908647359 @default.
- W1971031736 hasConcept C42219234 @default.
- W1971031736 hasConcept C71924100 @default.
- W1971031736 hasConcept C99454951 @default.
- W1971031736 hasConceptScore W1971031736C126322002 @default.
- W1971031736 hasConceptScore W1971031736C141071460 @default.
- W1971031736 hasConceptScore W1971031736C2776265017 @default.
- W1971031736 hasConceptScore W1971031736C2776301958 @default.
- W1971031736 hasConceptScore W1971031736C2778104916 @default.
- W1971031736 hasConceptScore W1971031736C2778269268 @default.
- W1971031736 hasConceptScore W1971031736C2778336525 @default.
- W1971031736 hasConceptScore W1971031736C2778661090 @default.
- W1971031736 hasConceptScore W1971031736C2778959117 @default.
- W1971031736 hasConceptScore W1971031736C2779161974 @default.
- W1971031736 hasConceptScore W1971031736C2780868729 @default.
- W1971031736 hasConceptScore W1971031736C2908647359 @default.
- W1971031736 hasConceptScore W1971031736C42219234 @default.
- W1971031736 hasConceptScore W1971031736C71924100 @default.
- W1971031736 hasConceptScore W1971031736C99454951 @default.
- W1971031736 hasIssue "06" @default.
- W1971031736 hasLocation W19710317361 @default.
- W1971031736 hasLocation W19710317362 @default.
- W1971031736 hasOpenAccess W1971031736 @default.
- W1971031736 hasPrimaryLocation W19710317361 @default.
- W1971031736 hasRelatedWork W1980752621 @default.
- W1971031736 hasRelatedWork W1982739364 @default.
- W1971031736 hasRelatedWork W2006322029 @default.
- W1971031736 hasRelatedWork W2067493511 @default.
- W1971031736 hasRelatedWork W2165652063 @default.
- W1971031736 hasRelatedWork W2387624618 @default.
- W1971031736 hasRelatedWork W2981730791 @default.
- W1971031736 hasRelatedWork W3027698964 @default.
- W1971031736 hasRelatedWork W4386104923 @default.
- W1971031736 hasRelatedWork W2559025777 @default.
- W1971031736 hasVolume "97" @default.
- W1971031736 isParatext "false" @default.
- W1971031736 isRetracted "false" @default.
- W1971031736 magId "1971031736" @default.
- W1971031736 workType "article" @default.